Menu Close

2020 Request for Proposals

The 2020 RFP Process Has Concluded

Required LOIs and invited full proposals can be submitted in response to this RFP until noon (EST) Feb 28th, 2020 and until 5:00 PM (EST), April 9th, 2020 respectively.

Applicants will be notified of the invitation to submit full proposals by March 6th, 2020, and funded applicants will have one year from the notice of award (until June 30, 2021) to complete their projects.

A letter of intent using the online form provided is required to ensure consistency of the proposed research with the research mission of the Consortium for Medical Marijuana (MMJ) Clinical Outcomes Research as defined by Florida statute, as well as to allow recruitment of external reviewers with subject matter expertise in the proposed area of inquiry.


The Consortium for Medical Marijuana Clinical Outcomes Research is comprised of public and private university member institutions within Florida. The Consortium provides awards to support clinical and translational research related to medical marijuana to investigators within member institutions.

The Consortium is charged by Florida statute to conduct and support “research that contributes to the body of scientific knowledge on the effects of the medical use of marijuana and informs both policy and medical practice related to the treatment of debilitating medical conditions with marijuana”.

This award mechanism will consider fully developed research studies that generate novel evidence, as well as studies intended to facilitate the collection and/or analysis of preliminary data that will support future extramural funding applications.

Research Priorities

The following are Consortium research priorities that were derived in consultation with scientific and subject matter experts, evidence review, and input from stakeholder engagement. Proposals addressing these priorities are encouraged:

  • Clinical Outcomes: with particular emphasis on the following conditions – chronic pain, anxiety, and symptomatic treatment of cancer
  • Route of Administration: effect of dosing and routes on efficacy and safety; of particular interest are studies that evaluate effects of smoking and vaping
  • Interactions of Medical Marijuana with other drugs/medications: with particular focus on medications that are commonly used by patients who seek medical marijuana treatment


All applicant principal investigators (PIs) must be faculty members of Consortium member institutions, which currently include:

  • Florida A&M University
  • Florida Atlantic University
  • Florida Gulf Coast University
  • Florida Memorial University
  • Florida International University
  • Florida State University
  • University of Central Florida
  • University of Florida
  • University of Miami

All applicants who propose human subject research must be in compliance with their institutional IRB investigator qualifications. Where applicable, investigators are required to demonstrate project IRB, IACUC, or other regulatory approval as appropriate, following notice of award. It is recommended that applicants seek regulatory approvals prior to receiving the notice of award to ensure no delay in project start.

Applicants may submit only one application for this RFP as the PI and there are no restrictions regarding the number of applications where the investigator is listed as a co-investigator.

All proposal submissions will be treated as new submissions regardless of previous participation in the Consortium grants program.


RFP AnnouncementFebruary 3rd, 2020
Letter of Intent DueNoon (EST), February 28th, 2020
Proposal Submission Deadline (EXTENDED)5:00 PM (EST), April 9th, 2020
Notice of AwardsJuly 1st, 2020
Award Funding PeriodJuly 1st, 2020 through June 30th, 2021

NOTE: Late submissions for LOIs or Proposals will not be accepted.